Press Releases

TAMPA, Fla., March 10, 2020 /PRNewswire/ -- Continental Benefits, a full-service Third Party Administrator focused on improving quality of care, has partnered with Regenexx, a network of leading interventional orthopedics clinics. The partnership allows Continental Benefits to offer its clients Regenexx procedures, which can intervene on up to 70% of elective ortho

SALT LAKE CITY, March 10, 2020 /PRNewswire/ -- The Bundesliga's VfL Wolfsburg will bolster its energy and nutritional needs with nutritional supplements from US manufactu

SAN DIEGO and TOKYO and WETTEREN, Belgium, March 10, 2020 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, announced today the formation of its External Advisory Board (EAB) to provide insight in

CEDAR KNOLLS, N.J., March 10, 2020 /PRNewswire/ -- In honor of National Nutrition Month®, Eggland's Best (EB), the nation's #1 selling branded egg, and

HANGZHOU, China and SHAOXING, China, March 10, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today the progress of the small sample clinical trial of Ganovo® and Ritonavir combination therapy on Novel Coronavirus Pneumonia. One of the treatment groups in this study is the group receiving oral Ganovo® and Ritonavir combin

KITZBÜHEL, Austria, March 10, 2020 /PRNewswire/ -- Interventional Systems (iSYS Medizintechnik GmbH, Austria) releases its new robotic platform, Micromate™ for use in Europe. The first six installations will occur in the beginning of the second quarter of this year, at the same time a 510(k) submission i

STOCKHOLM, March 10, 2020 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announced that the first patient with advanced liver cancer has been dosed in the phase Ib study of MIV-818. The MIV-818 phase I study (NCT03781934) consists of two parts: (i) the already completed phase Ia, which was a within-patient dose-escalation study, and (ii) the phase

OXFORD, England, March 10, 2020 /PRNewswire/ -- Oxford VR (OVR) announces the launch of OVR social engagement™ a ground-breaking and progressive behavioral health intervention using virtual reality technology to help individuals overcome anxious social avoidance, prev

BAAR, Switzerland and BERLIN, March 10, 2020 /PRNewswire/ -- CARAG AG, a Swiss privately held medical device development company, announced today the successful implantation of the first-ever transcatheter septal occluder with bioresorbable, metal-free framework, as part of a new international post-market registry. The study will grow the scientific body of evidenc

OSLO, Norway, March 10, 2020 /PRNewswire/ -- Financial calendar for Nordic Nanovector ASAFINANCIAL YEAR 201927.03.2020 - Annual ReportFINANCIAL YEAR 202027.08.2020 - Half-yearly Report30.04.2020 - Annual General Meeting